Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin ...

The objective of this study is to evaluate the efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with CHD and GID ...

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is recommended for patients with coronary heart disease (CHD) undergoing ...

Rivaroxaban plus aspirin vs. dual antiplatelet therapy in ... - Frontiers

Results: From January 2016 to December 2021, 455 patients received either clopidogrel plus aspirin or rivaroxaban plus aspirin following ...

Efficacy and Safety of Rivaroxaban Compared with Other Therapies ...

There was no evidence for differences between RIV plus ASA and dual antiplatelet therapy and vitamin K antagonists plus ASA. Similar results ...

Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular ...

For endovascular-treated patients, rivaroxaban reduced the risk of acute limb ischemia or major amputation of a vascular pathogenesis by 30% (HR ...

Additional file 2 of Efficacy and safety of rivaroxaban plus ...

Additional file 2 of Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary ...

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin ...

In the PIONEER AF-PCI trial, two rivaroxaban-based treatment regimens significantly reduced bleeding complications compared to conventional triple therapy ...

Peripheral Artery Disease Revascularization With Rivaroxaban and ...

The authors concluded that the safety of rivaroxaban plus aspirin following PAD revascularization was consistent regardless of clopidogrel use.

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin ...

The Gemini-ACS-1 study demonstrated that low-dose rivaroxaban did not increase clinically significant bleeding when used with clopidogrel or ...

Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior ...

Although in the acute setting, the ATLAS-2 trial (An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome) ...

Comparison efficacy and safety of different antiplatelet or - Medicine

Clopidogrel/prasugrel + aspirin (OR = 3.8, 95% credible intervals [CrI]: 1.3–12.0, P < .05) and aspirin + rivaroxaban 2.5 mg (OR = 3.1, 95%CrI: ...

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin ...

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal ...

Safety and Efficacy Evaluation of Antithrombotic Therapy with ...

It is noteworthy that a study showed that bleeding time was significantly prolonged by the combination of rivaroxaban and clopidogrel in approximately one-third ...

PC078. Rivaroxaban plus Aspirin Versus Standard Dual Antiplatelet ...

A postintervention regimen of rivaroxaban 2.5 mg twice daily for 90 days in combination with aspirin long term appears to be safe and has potential as an ...

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better ...

Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower ...

The secondary outcome of hospitalization for a coronary or peripheral cause was reduced with rivaroxaban overall with consistent effects ...

Concomitant Use of XARELTO with Dual Antiplatelet Therapy

VOYAGER PAD: Use of XARELTO with aspirin versus aspirin alone showed consistent efficacy and safety regardless of concomitant clopidogrel use. The addition of ...

CRT-100.12 Safety and Efficacy of Rivaroxiban Plus Clopidogrel in ...

Rivaroxaban (20 mg OD) plus clopidogrel (75 mg) for 12 months was safe and effective in participants with AF and UA who treated medically or PCI.

Rivaroxaban and Aspirin in Patients With Symptomatic Lower ...

Meaning Per this analysis, patients with high-risk lower extremity peripheral artery disease limb presentations or comorbidities, who are not at ...

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin ...

Abstract Background Dual antiplatelet therapy (DAPT) with aspirin and a P2Y 12 inhibitor is recommended for patients with coronary heart disease (CHD) ...